tiprankstipranks
Trending News
More News >
Co-Diagnostics Inc (CODX)
NASDAQ:CODX
US Market
Advertisement

Co-Diagnostics (CODX) Earnings Dates, Call Summary & Reports

Compare
1,637 Followers

Earnings Data

Report Date
Mar 19, 2026
Before Open (Confirmed)
Period Ending
2025 (Q4)
Consensus EPS Forecast
-0.12
Last Year’s EPS
-0.36
Same Quarter Last Year
Moderate Buy
Based on 2 Analysts Ratings

Earnings Call Summary

Q3 2025
Earnings Call Date:Nov 13, 2025|
% Change Since:
|
Earnings Call Sentiment|Neutral
The earnings call highlighted the company's strategic initiatives and international expansion efforts as major drivers of future growth. However, significant financial challenges remain, with declining revenue and continued net losses, albeit with improved operational efficiency.
Company Guidance
In the third quarter of fiscal year 2025, Co-Diagnostics, Inc. provided guidance emphasizing four primary growth pillars. These include the engagement of Maxim Group to explore strategic alternatives for their Indian joint venture, CoSara Diagnostics, potentially through a SPAC transaction; the establishment of CoMira, a joint venture with Arabian Eagle to expand their presence in Saudi Arabia and the MENA region; the launch of an AI business unit to enhance operational efficiency and diagnostics; and the initiation of clinical evaluations for their upper respiratory multiplex test. Financially, Co-Diagnostics reported a revenue of $0.1 million and a net loss of $5.9 million, with operating expenses reduced to $7.1 million for the quarter, demonstrating a focus on operational efficiency. The company aims to strengthen its balance sheet through strategic direct offerings totaling $10.8 million and is optimistic about multiple commercial launches expected in 2026.
Strategic Joint Ventures
Co-Diagnostics announced joint ventures with CoSara in India and CoMira in Saudi Arabia. The CoSara SPAC transaction is expected to unlock significant value, while CoMira marks expansion into 19 MENA countries, strengthening the company's international footprint.
AI Business Unit Launch
The launch of an AI business unit led by the Co-Dx Primer AI platform aims to enhance diagnostics, improve operational efficiency, and provide predictive epidemiological insights.
Upper Respiratory Multiplex Test
Initiation of clinical evaluations for a comprehensive respiratory panel detecting flu A, flu B, COVID-19, and RSV, supported by a RADx Tech grant from the NIH.
Improved Financial Efficiency
Operating expenses decreased from $10.6 million in Q3 2024 to $7.1 million in Q3 2025, reflecting operational efficiency improvements.

Co-Diagnostics (CODX) Earnings, Revenues Date & History

The upcoming earnings date is based on a company’s previous reporting, and may be updated when the actual date is announced

CODX Earnings History

Report Date
Fiscal Quarter
Forecast / EPS
Last Year's EPS
EPS YoY Change
Press Release
Slides
Play Transcript
Mar 19, 2026
2025 (Q4)
-0.12 / -
-0.36
Nov 13, 2025
2025 (Q3)
-0.19 / -0.16
-0.3250.00% (+0.16)
Aug 14, 2025
2025 (Q2)
-0.25 / -0.23
-0.258.00% (+0.02)
May 08, 2025
2025 (Q1)
-0.27 / -0.24
-0.3122.58% (+0.07)
Mar 27, 2025
2024 (Q4)
-0.34 / -0.36
-0.49427.13% (+0.13)
Nov 07, 2024
2024 (Q3)
-0.33 / -0.32
-0.2-60.00% (-0.12)
Aug 08, 2024
2024 (Q2)
-0.34 / -0.25
-0.3119.35% (+0.06)
May 09, 2024
2024 (Q1)
-0.21 / -0.31
-0.2-55.00% (-0.11)
Mar 14, 2024
2023 (Q4)
-0.20 / -0.49
-0.18-174.44% (-0.31)
Nov 09, 2023
2023 (Q3)
-0.29 / -0.20
-0.04-400.00% (-0.16)
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat
Missed

CODX Earnings-Related Price Changes

Report Date
Price 1 Day Before
Price 1 Day After
Percentage Change
Nov 13, 2025
$0.37$0.33-10.81%
Aug 14, 2025
$0.26$0.29+11.54%
May 08, 2025
$0.36$0.34-5.56%
Mar 27, 2025
$0.39$0.32-17.95%
Earnings announcements can affect a stock’s price. This table shows the stock's price the day before and the day after recent earnings reports, including the percentage change.

FAQ

When does Co-Diagnostics Inc (CODX) report earnings?
Co-Diagnostics Inc (CODX) is schdueled to report earning on Mar 19, 2026, Before Open (Confirmed).
    What is Co-Diagnostics Inc (CODX) earnings time?
    Co-Diagnostics Inc (CODX) earnings time is at Mar 19, 2026, Before Open (Confirmed).
      Where can I see when companies are reporting earnings?
      You can see which companies are reporting today on our designated earnings calendar.
        What companies are reporting earnings today?
        You can see a list of the companies which are reporting today on TipRanks earnings calendar.
          What is CODX EPS forecast?
          CODX EPS forecast for the fiscal quarter 2025 (Q4) is -0.12.
            What am I Missing?
            Make informed decisions based on Top Analysts' activity
            Know what industry insiders are buying
            Get actionable alerts from top Wall Street Analysts
            Find out before anyone else which stock is going to shoot up
            Get powerful stock screeners & detailed portfolio analysis